Pedunculopontine network dysfunction in Parkinson's disease with postural control and sleep disorders.

Gallea C, Ewenczyk C, Degos B, Welter ML, Grabli D, Leu-Semenescu S, Valabregue R, Berroir P, Yahia-Cherif L, Bertasi E, Fernandez-Vidal S, Bardinet E, Roze E, Benali H, Poupon C, François C, Arnulf I

Mov Disord. 2017 Feb 6. doi: 10.1002/mds.26923. [Epub ahead of print]

Simultaneous determination of MAO-A and -B activity following first time intake of an irreversible MAO-B inhibitor in patients with Parkinson's disease.

Müller T, Riederer P, Grünblatt E.

J Neural Transm (Vienna). 2017 Mar 15. doi: 10.1007/s00702-017-1705-z. [Epub ahead of print]

Falling upward with Parkinson's disease.

Buetow SA, Martínez-Martín P, McCormack B.

NPJ Parkinsons Dis. 2017 Sep 13;3:29. doi: 10.1038/s41531-017-0031-3. eCollection 2017. Review.

Self-management support programs for persons with Parkinson's disease: An integrative review.

Kessler D, Liddy C.

Patient Educ Couns. 2017 Oct;100(10):1787-1795. doi: 10.1016/j.pec.2017.04.011. Epub 2017 Apr 17. Review.

Models of LRRK2-Associated Parkinson's Disease.

Xiong Y, Dawson TM, Dawson VL.

Adv Neurobiol. 2017;14:163-191. doi: 10.1007/978-3-319-49969-7_9.

The Role of Astrocyte Dysfunction in Parkinson's Disease Pathogenesis.

Booth HDE, Hirst WD, Wade-Martins R.

Trends Neurosci. 2017 Jun;40(6):358-370. doi: 10.1016/j.tins.2017.04.001. Epub 2017 May 17. Review.

Pedestrian safety in patients with Parkinson's disease: A case-control study.

Ford KJ, Joop A, Memon RA, Wood KH, Ball K, Cutter GR, Schwebel DC, Amara AW.

Mov Disord. 2017 Oct 4. doi: 10.1002/mds.27124. [Epub ahead of print]

Traditional Chinese medicine for modern treatment of Parkinson's disease.

Han L, Xie YH, Wu R, Chen C, Zhang Y, Wang XP.

Chin J Integr Med. 2017 Jan 20. doi: 10.1007/s11655-016-2537-7. [Epub ahead of print] Review.

Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease.

Orr AL, Rutaganira FU, de Roulet D, Huang EJ, Hertz NT, Shokat KM, Nakamura K.

Neurochem Int. 2017 Oct;109:106-116. doi: 10.1016/j.neuint.2017.04.006. Epub 2017 Apr 20.

Symptom Dimensions of Depression and Apathy and Their Relationship With Cognition in Parkinson's Disease.

Szymkowicz SM, Dotson VM, Jones JD, Okun MS, Bowers D.

J Int Neuropsychol Soc. 2017 Oct 16:1-14. doi: 10.1017/S1355617717001011. [Epub ahead of print]

Stigma Experienced by Parkinson's Disease Patients: A Descriptive Review of Qualitative Studies.

Maffoni M, Giardini A, Pierobon A, Ferrazzoli D, Frazzitta G.

Parkinsons Dis. 2017;2017:7203259. doi: 10.1155/2017/7203259. Epub 2017 Jan 24. Review.

Cognition in non-demented Parkinson's disease vs essential tremor: A population-based study.

Sánchez-Ferro Á, Benito-León J, Louis ED, Contador I, Hernández-Gallego J, Puertas-Martín V, Bermejo-Pareja F.

Acta Neurol Scand. 2017 Mar 5. doi: 10.1111/ane.12752. [Epub ahead of print]

Increase in Parkinson's disease-related mortality among males in Northern Italy.

Fedeli U, Schievano E.

Parkinsonism Relat Disord. 2017 Jul;40:47-50. doi: 10.1016/j.parkreldis.2017.04.008. Epub 2017 Apr 12.

Diagnosis and Management of Parkinson's Disease.

Tarakad A, Jankovic J.

Semin Neurol. 2017 Apr;37(2):118-126. doi: 10.1055/s-0037-1601888. Epub 2017 May 16.

Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson's Disease.

Yang XQ, Lauzon B, Seergobin KN, MacDonald PA.

Front Hum Neurosci. 2018 Jan 4;11:642. doi: 10.3389/fnhum.2017.00642. eCollection 2017.